Impact of Breast Cancer on Human Folliculogenesis

Plain-language summary

This study examines the impact of breast cancer on the development of egg cells (folliculogenesis). Women aged 18 to 38 who are undergoing their first hormonal stimulation cycle and have not previously received cancer treatment may take part. This is a study without a clinical phase; it is currently not recruiting but is still ongoing (active, not recruiting).

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Active, not recruiting

Sponsor

University Hospital, Clermont-Ferrand

Intervention

Ovarian stimulation

Start date

1/11/2019

Estimated completion

8/31/2027

Countries

France

Related genes

Locations

• Clermont-Ferrand, France

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Women above 18 years old and below 38 years old
* First hormonal stimulation cycle
* No dysovulation
* No cancer treatments prior fertility preservation (tumour resection, chemotherapy, radiotherapy)
* Women capable of giving written informed consent to participate in the research study
* Affiliated to social welfare service

Exclusion Criteria:

* Women below 18 years old and above 38 years old
* Endocrine disease
* Endometriosis
* Any cancer treatments prior fertility preservation (tumour resection, chemotherapy, radiotherapy)
* Previous hormonal stimulation cycle of less than six months